Mechanism of the mitogenic influence of hyperinsulinemia

Diabetology and Metabolic Syndrome

Volumn 3, Issue 1, 2011, Pages

  Draznin, Boris ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; INSULIN; METFORMIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN FARNESYLTRANSFERASE; RAF PROTEIN; RAS PROTEIN; SOMATOSTATIN; VASCULOTROPIN;

ADIPOCYTE; BREAST CELL; CANCER CELL; CARBOHYDRATE INTAKE; CELL MEMBRANE; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; ISOPRENYLATION; LIFE EXPECTANCY; LIVER CELL; MITOGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVIEW; VASCULAR SMOOTH MUSCLE;

EID: 79958272949     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-3-10     Document Type: Review

References (20)

1. Evidence for a functional role of Shc proteins in mitogenic signaling induced by insulin, insulin-like growth factor-1, and epidermal growth factor. T Sasaoka DW Rose BH Jhun AR Saltiel B Draznin JM Olefsky, J Biol Chem 1994 269 13689 13694 7513704 (Pubitemid 24206151)
2. Mitogenic properties of insulin and insulin analogs mediated by the insulin receptor. D Ish-Shalom CT Christoffersen P Vorwerk N Sacerdoti-Sierra RM Shymko D Naor P DeMeyts, Diabetologia 1977 40 525 531
3. Insulin's effect on farnesyltransferase: Specificity of insulin action and potentiation of nuclear effects of IGF-1, EGF, and PDGF. ML Goalstone JW Leitner K Wall L Dolgonos KI Rother D Accili B Draznin, J Biol Chem 1998 273 23892 23896 10.1074/jbc.273.37.23892 9727002
4. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. B Draznin P Miles Y Kruszynska J Olefsky J Friedman I Golovchenko R Stjernholm K Wall M Reitmen D Accili R Cooksey D McClain M Goalstone, Endocrinology 2000 141 1310 1316 10.1210/en.141.4.1310 10746633 (Pubitemid 32269097)
5. Ras activation by insulin and epidermal growth factor through enhanced exchange of guanine nucleotides on p21Ras. SL Medema AMM deVries-Smits GCM van der Zon JA Maasen JL Bos, Mol Cell Biol 1993 13 153 162
6. Protein prenylation: Molecular mechanisms and functional consequences. FL Zhang PJ Casey, Annu Rev Biochem 1996 65 241 269 10.1146/annurev.bi.65.070196. 001325 8811180 (Pubitemid 26250610)
7. Effect of insulin on farnesyltransferase activity in 3T3-L1 adipocytes. ML Goalstone B Draznin, J Biol Chem 1996 271 27585 27589 10.1074/jbc.271.44. 27585 8910345 (Pubitemid 26367323)
8. Insulin stimulates the phosphorylation and activity of farnesyltransferase via the Ras-Map Kinase pathway. ML Goalstone K Carel JW Leitner B Draznin, Endocrinology 1997 138 5119 5124 10.1210/en.138.12.5119 9389491 (Pubitemid 27509668)
9. Hyperinsulinemia potentiates activation of p21Ras by growth factors. JW Leitner T Kline K Carel ML Goalstone B Draznin, Endocrinology 1997 138 2211 2214 10.1210/en.138.5.2211 9112423 (Pubitemid 27180843)
10. Enhanced insulin signaling via Shc in human breast cancer. C Finlayson J Chappell JW Leitner ML Goalstone M Garrity S Nawaz TP Ciaraldi B Draznin, Metabolism 2003 52 1606 1608 10.1016/S0026-0495(03)00311-1 14669164
11. Molecular mechanisms of insulin resistance that impact on cardiovascular biology. CCL Wang ML Goalstone B Draznin, Diabetes 2004 53 2735 2740 10.2337/diabetes.53.11.2735 15504952 (Pubitemid 39425897)
12. Increased amounts of farnesylated p21 Ras in tissues of hyperinsulinemic animals. ML Goalstone K Wall JW Leitner T Kurowski N Ruderman SJ Pan JL Ivy DE Moller B Draznin, Diabetologia 1999 42 310 316 10.1007/s001250051156 10096783 (Pubitemid 29111437)
13. Fetal hyperinsulinemia increases farnesylation of p21 Ras in fetal tissues. E Stephens PJ Thureen ML Goalstone MS Anderson JW Leitner WW Hay Jr B Draznin, Am J Physiol 2001 281 217 E223
14. Inhibition of phosphatidylinositol 3-kinase enhances mitogenic action of insulin in endothelial cells. M Montagnani I Golovchenko I Kim GY Koh ML Goalstone AN Mundhekar M Johansen DF Kucik MJ Quon B Draznin, J Biol Chem 2002 277 1794 1799 10.1074/jbc.M103728200 11707433 (Pubitemid 34968751)
15. Increased farnesylation of p21-Ras and neonatal macrosomia in women with gestational diabetes. P Thureen M Reece D Rodden L Barbour J Chappell JW Leitner RO Jones B Draznin, J Pediatrics 2006 149 871 873 10.1016/j.jpeds.2006.08.071 (Pubitemid 44816351)
16. Diet, delusion and diabetes. L Sawyer EAM Gale, Diabetologia 2009 52 1 7 19018511
17. Insulin glargine use and short-term incidence of malignancies - a population-based follow-up study in Sweden. JM Jonasson R Ljung M Talbäck B Haglund S Gudbjörnsdttir G Steineck, Diabetologia 2009 52 1745 1754 10.1007/s00125-009-1444-2 19588120
18. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. SL Bowker SR Majumdar P Veugelers JA Johnson, Diabetes Care 2006 29 254 258 10.2337/diacare.29.02.06.dc05-1558 16443869 (Pubitemid 44106500)
19. Metformin and pathologic complete response to neoadjuvant chemotherapy in diabetic patients with breast cancer. S Jiralerspong SL Palla SH Giordano F Meric-Bernstam C Liedtke CM Barnett L Hsu MC Hung GN Hortobagyi AM Gonzalez-Angulo, J Clin Onc 2009 27 3297 3302 10.1200/JCO.2009.19.6410
20. Effects of chronic hyperinsulinemia in insulin-resistant patients. S Muntoni S Muntoni B Draznin, Current Diabetes Reports 2008 8 233 238 10.1007/s11892-008-0040-z 18625122